Frontlight ResearchEarly access
Trial site
London Regional Cancer Program of the Lawson Health Research Institute
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 22 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Active, not recruiting3 trials
- Completed1 trial
- Recruiting1 trial
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's3 trials
- Centre hospitalier de l'Université de Montréal (CHUM)1 trial
- Mark Vincent1 trial
Running trials
Recruiting
Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge
Active, not recruiting
Active, not recruiting
Active, not recruiting
Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026